NCT00952757View on ClinicalTrials.gov

Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
APS-related HyperprolactinaemiaSchizophreniaBipolar Disorder
Trial Locations (6)

34004

Hospital San Telmo, Palencia

37007

Hospital Universitario de Salamanca, Salamanca

47001

Servicio de Psiquiatria de Valladolid, Valladolid

49007

Servicio de Psiquiatría, Zamora

05001

Servicio de Psiquiatría, Ávila

09006

Servicio de Psiquiatria, Burgos

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Investigaciones Médicas Montejo S.L.

OTHER